<DOC>
	<DOCNO>NCT00066170</DOCNO>
	<brief_summary>This study conduct randomize , double blind , double-dummy , placebo-controlled , parallel-group trial patient diagnose narcolepsy . Volunteers trial require make 5 visit 14 week participate expert physician practitioner various sleep narcolepsy evaluation diary also collect . Participants take assigned medication course trial . Subjects 25 % probability receive placebo drug ( modafinil Xyrem ) . All subject volunteer must meet criterion narcolepsy evidence daytime sleepiness . Patients incur personal medical expense due participation trial . The sponsor cover visit cost cover insurance fund patient expense travel .</brief_summary>
	<brief_title>Trial Comparing Effects Xyrem Taken Orally Modafinil With Placebo Treating Daytime Sleepiness Narcolepsy</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Sodium Oxybate</mesh_term>
	<criteria>INCLUSION CRITERIA Patients include trial : Have sign date informed consent prior begin protocol require procedure . Are willing able complete entire trial describe protocol . Are 18 year age old . Fulfill International Classification Sleep Disorders criterion diagnosis narcolepsy . Are take stable dos modafinil ( 200 600 mg/day ) treatment daytime sleepiness period three month great modafinil dose stable least 1 month prior enter trial Females may include surgically sterile , two year postmenopausal , childbearing potential , use medically accept method birth control ( e.g. , barrier method spermicide , oral contraceptive , abstinence ) agree continue use method duration trial . In opinion investigator adequate support duration trial include transportation trial site . In addition , investigator 's assessment clinically indicate , patient willing operate car heavy machinery duration trial long investigator deem clinically indicate . EXCLUSION CRITERIA Patients exclude trial : Have receive gammahydroxybutyrate last 30 day . Have take investigational therapy within 30day period prior initial screen visit ( Visit 1 ) trial . Have sleep apnea syndrome , define Apnea Index &gt; 10 per hour AHI ( Apnea Hypopnea Index ) great 15 per hour , cause daytime sleepiness , disorder ( ) consider primary cause excessive daytime sleepiness ( e.g. , severe periodic leg movement syndrome determine investigator , sleep apnea , sleep deprivation ) . Are take hypnotic , tranquilizer , antihistamine ( except nonsedating antihistamine ) , benzodiazepine clonidine start baseline period . Patients take anticonvulsant eligible participate event willing washout anticonvulsant trial . Are experience major illness , include unstable cardiovascular , endocrine , neoplastic , gastrointestinal , hematologic , hepatic , immunologic , metabolic , neurological ( narcolepsy/cataplexy ) , pulmonary , and/or renal disease would place patient risk trial compromise objective outline protocol . Have psychiatric disorder , major affective psychotic disorder , problem , investigator 's opinion , would preclude patient 's participation completion trial compromise reliable representation subjective symptom . Have current recent ( within one year ) history substance use disorder include alcohol abuse define DSMIV . Have serum creatinine great 2.0 mg/dL , abnormal liver function test ( SGOT [ AST ] SGPT [ ALT ] twice upper limit normal ) , elevate serum bilirubin ( 1.5 time upper limit normal ) , pretrial ECG result demonstrate clinically significant arrhythmia , great first degree AV block history myocardial infarction within last six month . Have occupation require variable shift work routine night shift . Have clinically significant history seizure disorder either past present , history clinically significant head trauma ( i.e. , concussion result clinically significant loss consciousness ) past invasive intracranial surgery , take anticonvulsant medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Narcolepsy</keyword>
	<keyword>Daytime Sleepiness</keyword>
	<keyword>Daytime sleepiness narcolepsy</keyword>
</DOC>